Financials
- Market Capitalization 9.22 B
- Employee 730
- Founded 1998
- CEO N/A
- Website www.corcept.com
- Headquarter Delaware, United States
- FIGI BBG000BKJG33
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
115.17
Rapporto prezzo/fatturato
6.09
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 924 | NUVL Nuvalent, Inc. - Class A Common Stock | 123.94 USD | +0.03% | +0.19% | +0.52% | +30.53% | 9.79 B USD | ||
| 948 | IONS Ionis Pharmaceuticals, Inc. - Common Stock | 56.75 USD | -2.58% | -32.78% | -22.78% | -21.32% | 9.38 B USD | ||
| 967 | KYMR Kymera Therapeutics, Inc. - Common Stock | 110.40 USD | -7.50% | -4.18% | +27.97% | +86.80% | 9.08 B USD | ||
| 968 | HALO Halozyme Therapeutics, Inc. - Common Stock | 76.11 USD | -0.12% | -6.56% | +8.54% | +13.94% | 9.03 B USD |